Researchers evaluated the patient-specific factors that were associated with a greater risk of advanced disease at the time of melanoma diagnosis.

DB-1305/BNT325 was generally well tolerated and exhibited “very encouraging and durable antitumor activity in ovarian cancer patients,” said Maria Rubinstein, MD.

A propensity to compare oneself to others increases breast cancer survivors’ social anxiety regarding body image; however, having a high self-regard can mitigate this effect.

Largest number of cancers was projected to result from abdomen and pelvic CT in adults, reflecting 37 percent of those 103,000 cancers.

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Until prospective data are available, researchers recommend that patients with ER-low breast cancer “should be counseled regarding the potential benefit” of adjuvant endocrine therapy.

Researchers sought to assess the access to CAR-T therapy for patients within community-based and transplant cell therapy networks.

Medical staff and patients with CRC reported that intermittent symptom management did not provide sufficient support to patients at home.

Discrepancies between clinical and pathologic staging of muscle-invasive bladder cancer (MIBC) are found in three-quarters of patients following radical cystectomy without neoadjuvant therapy, ...

DNA detection at baseline was associated with worse recurrence-free, overall survival in BRAFV600-mutant stage III melanoma.